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Abstract: A compound herbal formulation (POL4) is used traditionally in interior parts (Distt. Badin) of Sindh, Pakistan, 
for the treatment of metabolic disorders like diabetes and hyperlipidemia. This study is aimed to determine the 
effectiveness of POL4 and its ingredients in hyperlipidemia and associated endothelial dysfunction and hypertension. 
POL4 is composed of equal proportion of Nigella sativa, Cichorium intybus, Trigonella foenum graecum and Gymnema 
sylvestre mixed in powdered form. Chronic (6 to 7 weeks)  administration of POL4 and its ingredients mixed in diet 
caused a notable attenuation in total cholesterol, low density lipoprotein cholesterol, triglycerides, atherogenic index, C-
reactive protein and glucose, while it has increased high density lipoprotein levels. POL4 intervention markedly (p<0.01) 
reduced systolic blood pressure in rats to 127±1.92 vs. 145.4±1.07 mm of Hg using tail-cuff method and significantly 
(p<0.05) improved endothelium-dependent relaxation (75±2.88 vs. 82.75±1.22%) to acetylcholine  in isolated aortae of 
rats in treatment groups using force transducer and PowerLab system. Similar activities were assessed on the part of 
ingredients of POL4. These findings indicate that POL4 and its ingredients possess antihyperlipidemic, endothelium-
dependent modulatory and antihypertensive activities, thus providing an evidence to the vernacular use of POL4 in 
hyperlipidemia and hypertension.   
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INTRODUCTION  
 
Persistent hyperlipidemia is a major contributing factor 
precipitating cardiovascular disorders (CVDs) such as, 
hypertension, myocardial infarction, peripheral artery and 
coronary artery diseases (Orsó et al., 2009). 
Hyperlipidemia expedites the process of atherosclerosis 
and its consequences of developing multi-vessels disease, 
heart failure and stroke. Controlled lipid levels achieved 
by non-pharmacological or pharmacological interventions 
are known to protect from cardiovascular events 
(Scicchitano et al., 2014). It is well documented that pre-
hyperlipidemia is highly prevalent in developing (around 
80%) countries including Pakistan compared to the 
developed countries (Dodani et al., 2008), which might be 
associated with sedentary life style and unhealthy dietary 
habits. The available treatment options for hyperlipidemia 
include statins, fibrates, bile acid sequestrants and niacin, 
however, their prolonged use is associated with multiple 
adverse effects like rhabdomyolysis, cardiomyopathy, 
myopathy, osteoporosis, constipation, intolerance and 
poor compliance (Last et al., 2011; Casula et al., 2012). 
In Asian countries including Pakistan, the alternative 
approaches, especially the use of herbal remedies and  
supplements are becoming very popular nowadays for 
their medical uses (Kajal et al., 2016).Herbal remedies 
have gained maximum attention in current era because of 
the presence of millions of constituents offering diverse 
range of activities with inbuilt potential to nullify 
associated adverse effects (Salvamani et al., 2014). One 
of the oldest traditional systems of the world, Greeco-
Arab/Tibb-e-Unani medicine is commonly practiced in 
South Asian countries. In our settings due to cultural 
acceptance, people prefer using medicinal plants or herbal 
formulations for various chronic ailments like 
constipation and diarrhea (Mehmood et al., 2015), 
hypercholesterolemia (Naz et al., 2016), hypertension and 
vascular resistance (Aziz et al., 2013; 2009). Similarly, 
formulations like a combination of S. reticulate, C. 
zeylanicum, L. speciosa, C. sinensis and G. sylvester for 
diabetes (Baig et al., 2014), Angiosifa(Parasuraman et al., 
2013) and Itrifal Saghir (Kamali et al., 2012) are popular 
for their therapeutic use as antihyperlipidemic and anti-
obesity, respectively. A compound herbal formulation 
(POL4) is popular in our system of traditional medicine 
for its medicinal utility in cardiometabolicdisorders (table 
1), however no report is available in the literature to 
rationalize its medicinal uses in hyperlipidemia and 
hypertension.  
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This study is aimed to validate the medicinal use of the 
parent formulation and its ingredients in hyperlipidemia, 
endothelial dysfunction and hypertension using high fat 
diet-induced hyperlipidemic rat model.  
 
MATERIALS AND METHODS 
 
Identification and preparation of polyherbal (POL4) 
formulation 
The ingredients [N. sativa (Ns), C. intybus (Ci), T. foenum 
graecum (Tfg) and G. sylvestre (Gs)] of polyherbal 
(POL4) formulation were procured from Rehmania Pinsar 
Store, Sargodha and samples were identified by Dr. 
Muhammad Amin Ullah Shah, Taxonomist, Department 
of Botany, University of Sargodha, Sargodha, Pakistan. 
The individual samples were deposited in the faculty 
herbarium with following voucher numbers; N. sativa 
(Malik-632), C. intybus (Malik-633), T. foenum graecum 
(Malik-634) and G. sylvestre (Malik-635). All the 
ingredients were powdered and mixed in equal parts to 
compose POL4. For further studies, the parent formulation 
and its ingredients were mixed in the diet of different 
HFD-fed animal groups. 
 
Animals 
Sprague-Dawley rats (180-250g) of either sex, kept at the 
“Animal House” of Aga Khan University, Karachi, were 
used in this study. The animals were maintained at 
moderate temperature (23±5°C), acceptable relative 
humidity (55±5%), 12-hr light/dark periods and were kept 
in plastic cages containing sawdust (changed after two 
days). Animals were given normal diet and tap water. All 
the animals were grouped at random in desired number of 
groups by numbering method and were acclimatized for 5 
to 7 days before starting the experiment. The 
experimental protocol were approved from institutional 
ethics committee at University of Sargodha, Sargodha, 
Pakistan.  
 
Chemicals 
Cholesterol, cholic acid, atorvastatin, acetylcholine and 
phenylephrine were sourced from Sigma Chemicals, St. 
Louis, MO, USA. Isoflurane was obtained from the 
Pharmacy of Aga Khan University Hospital, Karachi, 
Pakistan. Butterfat was procured from United King 
Bakers, Bahadurabad, Karachi, Pakistan. The reagents for 
the assessment of serum total cholesterol, low-density 
lipoprotein cholesterol, high-density lipoprotein-
cholesterol, triglycerides, glucose and C-reactive protein 
levels were purchased from Roche Diagnostic Karachi, 
Pakistan, while their estimation was carried out using 
Cobas c111 autoanalyzer diagnostic system (Roche 
Diagnostics International Ltd., Switzerland). 
 
Preparation of different diets and intervention  
Different diets were used in this study. Normal diet (ND) 
was developed at the animal house of Aga Khan 
University. ND consists of (gram/kilogram): fiber 380, 
flour 380, molasses 12, powdered milk 150, sodium 
chloride 5.8, vegetable oil 38, potassium metabisulphate 
1.2, nutrivet-L 2.5, fish meal 170. A total of 56 rats were 
randomly divided into 8 groups. Animals in group 1 (n=7) 
were administered the normal diet. High fat diet (HFD) 
was prepared using combination of cholesterol, cholic 
acid and butter fat (2, 0.5 and 5% w/w), respectively, an 
addition to normal diet components for 6-7 weeks (Aziz 
et al., 2013).Animals in groups 2-8 (n=7 in each group) 
were administered HFD. The animals in groups 4-8 were 
Table 1: Showing description of the ingredients of compound herbal formulation 
 
Ingredients of 
POL4(Botanicals) 
Vernacular 
names/part used Family 
Medicinal uses 
 
Phytochemical 
Constituents 
Nigella sativa, L. Black seed, 
Kalonji /seeds 
Ranunculaceae  Hypocholesterolemic, 
hypoglycemic, 
cardiodepressant(Razavi and 
Hosseinzadeh, 2014) 
Flavonoids, saponins, 
thymoquinone and 
tocopherols (Khan and 
Afzal, 2016) 
Cichorium 
intybus, L. 
Chicory, Kasni / 
seeds 
Asteraceae Hypocholesterolemic, 
hypoglycemic, 
cardiodepressant, cardiotonic 
(Nadkarni, 1986; Street et al., 
2013). 
Tannins, flavonoids, 
saponins and 
caffeoylquinic acid 
(Street et al., 2013) 
Trigonella 
foenum  
graecum, L. 
Fenugreek, 
Methi /seeds 
Fabaceae Hypocholesterolemic, 
antidiabetic,  
hypotriglyceridemic (Duke et 
al., 2002; Chaturvedi et al., 
2013). 
Flavonoids, diosgenin, 
trigonelline and 4-
hydroxyisoleucine 
(Khorshidian et al., 2016) 
Gymnema 
sylvestre, R.Br. 
Gurmar booti / 
leaves 
Asclepiadaceae Hypocholesterolemic, 
cardiotonic, hypoglycemic, 
antiobesity (Nadkarni, 1986; 
Tiwari et al., 2014). 
Flavonoids, saponins, 
tannins, gymnemic acid 
and deacylgemnemic acid 
(Tiwari et al., 2014) 
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administered POL4 and its ingredients mixed in diet at a 
dose of 6% w/w, respectively. The animals in group 3 
were administered atorvastatin (a standard lipid lowering 
drug), at 10mg/kg/day dissolved in distilled water and 
given through oral gavage (Belagali et al., 2013). All 
measures were ensured for uniform mixing of POL4 and 
its ingredients with normal diet. 
 
Assessment ofnon-invasive blood pressure in non-
anaesthetized rats  
 Non-invasive blood pressure was recorded at day 0 and at 
week 6 and/or 7 of the study using  tail cuff 
plethysmography (Model 92, IITC Inc., Woodland Hills, 
USA) joined with PowerLab (4/25) data attainment 
system linked to a computer with installed software of 
Chart 5.3 (AD Instruments, Sydney, Australia). Prior to 
the study protocol, the animals were given training skills 
for easy blood pressure measurement. As soon as the 
animals got acclimatized for these procedures, 4–6 
measurements, within time interval of 4-8 min, of systolic 
blood pressure in non-anaesthetized rats were attained and 
the mean values were calculated accordingly. Possible 
experimental variables like body temperature at 27°C, 
respiration, body motion and noise intensity were made 
minimum to get quality results (Aziz et al., 2009). 
 
Measurement of endothelium-dependent vasorelaxation 
in rat aortic preparations  
At terminal day of the experimental protocol, rats fasted 
for 12-16 hr were euthanized followed by anesthesia with 
isoflurane (2-5% v/w) by inhalation in a closed chamber 
until achievement of deep anesthesia. Dissection was 
performed at earliest to remove thoracic aortae. All the 
aortae were shifted to Kreb's solution with ingredients in 
mmol/L: [NaCl (118.4), KCl (4.7), KH2PO4 (1.2), MgSO4 
(1.20, NaHCO3 (25), glucose (11) and CaCl2 (2.5) with 
pH 7.4], cleaned of attached fatty tissues and were sliced 
into rings of 2 to 3 mm length. Afterward aortic rings 
were immersed in tissue bath assembly loading Kreb's 
solution at 37°C, bubbled with carbogen (95% O2 and 5% 
CO2), connected with a force transducer (50-7905, 
Harvard Apparatus, USA) and PowerLab data recording 
system (Model ML845, AD Instruments, Australia). The 
aortic rings were stabilized for 45 min at normal tension 
of 2g, with refreshing physiological salt solution at every 
15 min. After stabilization, acetylcholine concentration 
response curves (ACh; 1×10−8 to 10−4mol/L) were 
constructed on phenylephrine (P.E; 1×10−6mol/L)-induced 
contractions (Amin et al., 2015). 
 
Biochemical estimations 
Estimation of lipid profile, glucose and CRP 
The rats were exposed to isoflurane (2-5% v/w by 
inhalation) in a closed chamber until fully anesthetized. 
The blood samples were withdrawn in vacutainer by 
cardiac puncture from overnight fasted rats. The blood 
samples were centrifuged at 3000 rpm for 10min 
(Beckman Coulter Allegra X-22, USA) to extract serum. 
The estimation of serum total cholesterol (TC), low-
density lipoprotein-cholesterol, high-density lipoprotein-
cholesterol (HDL-C), triglycerides, glucose and C-
reactive proteins was carried out using Cobas c111 auto 
analyzer. Body weights were also measured for the 
determination of weight variations. Atherogenic index 
(AI) and coronary risk index (CRI) were calculated using 
formula: AI= TC-HDL-C/HDL-C and CRI= TC/HDL-C. 
 
STATISTICAL ANALYSIS 
 
The data was presented as means ± S.E.M. Student's t-test 
was applied for comparison between two groups, , while 
One-way ANOVA (analysis of variance) was applied to 
compare means in multiple groups by Dunnett's and/or 
Tukey’s post-test. P value of less than 0.05 was accounted 
significantly different. All graphs were constructed using 
GraphPad Prism software (GraphPad Software, 
California, USA). 
 
RESULTS 
 
Effects of treatment on serum parameters in high fat 
diet-induced hyperlipidemic rats  
Chronic administration of high fat diet (HFD) caused a 
significantly increase in serum total cholesterol (TC), low 
density lipoprotein-cholesterol (LDL-C), triglycerides 
(TG), C-reactive proteins (CRP), atherogenic index (AI) 
and coronary risk index (CRI), while it has decreased the 
high density lipoprotein-cholesterol (HDL-C) compared 
to normal diet control. Administration of POL4 and its 
ingredients to HFD-fed rats at a dose of 6% w/w reversed 
the raised parameters including TC, LDL-C, TG, AI, CRI 
and CRP, while this intervention has also cause a 
significantly rise in HDL-C levels compared to HFD-fed 
rats without any treatment. Similar effects have been 
observed on the part of positive control of atorvastatin (10 
mg/kg/day, oral gavage), a standard lipid lowering agent. 
The body weight was decreased due to slight reduction in 
daily feed intake in treatment groups compared to control. 
The comparative effect of different groups on selected 
serum parameters has been presented in table 2.  
 
Effect of different treatments on systolic blood pressure  
The chronic administration of POL4 and its ingredients to 
high fat diet (HFD)-fed rats significantly reduced systolic 
blood pressure to 127±1.92 vs. 145.4±1.07mm of Hg 
(mean ± SEM; n=6–7). The comparative systolic blood 
pressure lowering effect in different groups has been 
presented in fig. 1. 
 
Effect of treatment on endothelium-dependent reactivity 
Administration of POL4 and its ingredients to HFD-fed 
rats caused significant improvement in endothelium-
dependent relaxation by augmenting acetylcholine (ACh)-
mediated relaxation to 75.0±2.88 vs. 82.75±1.22% (n=6–
7). The HFD administration to rats resulted in 
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endothelium dysfunction which was evident by resistance 
to ACh-mediated inhibitory response in the isolated aortic 
rings as shown in fig. 2. The comparisons of ACh 
concentration-response curves in the aortic preparations 
of different treatment groups were presented in fig. 2. 
DISCUSSION  
 
In view of the folkloric medicinal use of ingredients of 
POL4 and the combined formulation in cardiometabolic 
disorders like hyperlipidemia and hypertension(Duke et 
Table 2: Effect of different treatments on serum parameters of HFD-fed rats 
 
Parameters ND HFD HFD + Atorva 
HFD + 
POL4 
HFD + 
N. sativa 
HFD + 
C. intybus 
HFD + 
T. foenum 
graecum 
HFD + 
G. 
sylvestre 
TC (mg/dL) 73.5 ± 
7.75 
317.2 ± 
11.82### 
143.8 ± 
5.29*** 
169.2 ± 
15.47*** 
164.4 ± 
11.05*** 
156.5 ± 
8.42*** 
175.4 ± 
6.63*** 
177.0 ± 
8.00*** 
LDL-C (mg/dL) 38.7 ± 
4.66 
267.6 ±  
8.47### 
97.8 ± 
5.25*** 
121.2 ± 
10.05*** 
133.6 ± 
9.46*** 
105.8 ± 
6.72*** 
145.2 ± 
7.33*** 
164.8 ± 
9.12*** 
HDL-C (mg/dL) 33.2 ± 
1.32 
20.2  ± 
1.45### 
25.2 ± 
1.26ns 
28.4 ± 
3.65** 
27.9 ± 
2.05** 
26.9  ± 
2.14* 
27.2 ± 
1.15* 
26.1 ± 
3.94* 
TG (mg/dL)  64.7 ±  
4.95 
83.5 ± 
5.56### 
75.2 ± 
1.25* 
74.8 ± 
3.76** 
75.7 ± 
3.52* 
76.4 ± 
2.45* 
74.3 ± 
3.58** 
75.9 ± 
5.90* 
AI  1.35 ± 
0.17 
14.66 ± 
3.35### 
4.72 ± 
1.40** 
4.94 ± 
1.29** 
4.80 ± 
0.96** 
5.0 ± 
1.63** 
5.23 ± 
1.46** 
6.73 ± 
0.95* 
CRI 2.3 ± 0.36 15.7 ± 
2.02### 
5.6  ± 
1.14*** 
5.7 ± 
0.95***  
5.8 ± 
1.07***  
6.1 ± 
0.75*** 
6.3 ± 
1.02*** 
5.1 ±  
1.24*** 
Glucose  mg/dL) 109.7 ± 
5.62 
119.4 ± 
4.17## 
112.2 ± 
2.12ns 
81.2 ± 
4.64*** 
83.6 ± 
5.53*** 
86.8 ± 
7.12*** 
73 ± 
4.34*** 
62.2 ± 
5.15*** 
CRP (mg/L) 0.026 ± 
0.016 
0.153 ± 
0.83### 
0.147± 
0.027ns 
0.144 ± 
0.034* 
0.145 ± 
0.092* 
0.146 ± 
0.042ns 
0.144 ± 
0.052* 
0.147 ± 
0.062ns 
Weight variation 
(%age) 
32.2 ± 
1.98 
47.8  ± 
2.22### 
40.2 ± 
1.05* 
37.2 ± 
1.56** 
36.4 ± 
2.33** 
39.2 ± 
1.46* 
37.7 ± 
1.68** 
38.4 ± 
2.11** 
 
Values shown are means ± SEM, n=7, ###p<0.001 and ##p<0.01 compared to ND (unpaired student’s t-test), while ns (non-
significant),*p<0.05, **p<0.01 and ***p<0.001 compared to HFD (One way-ANOVA followed by Tukey’s post-test).  
POL4 (poly herbal formulation); Ns (N. sativa); Ci (C. intybus); Tfg (T. foenum graecum); Gs (G. sylvestre); ND (normal diet); HFD 
(high fat diet); TC (total cholesterol); LDL-C (low density lipoprotein-cholesterol); HDL-C (high density lipoprotein-cholesterol); 
TG (triglycerides); CRP (C-reactive protein); AI (atherogenic index) and CRI (coronary risk index). 
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Fig. 1: Effect of different treatments on systolic blood pressure in HFD-fed rats 
Data represent the means ± SEM of 6 to 7 determinants. ***p<0.001 shows a comparison of ND vs. HFD (unpaired student’s t-test), 
while ns (non-significant), #p<0.05 and ##p<0.01 show a comparison of treatment groups vs. HFD (one-way ANOVA followed by 
Dunnett’s test). POL4 (polyherbal formulation); Ns (N. sativa); Ci (C. intybus); Tfg (T. foenum graecum); Gs (G. sylvestre); ND 
(normal diet); HFD (high fat diet); Atorva (atorvastatin). 
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Fig. 2: Effect of different treatments on endothelium-dependent relaxation in isolated aortae of HFD-fed rats. 
Data show the means ± SEM of 6 to 7 sets of experiments. ***p<0.001 shows a comparison of HFD with ND (Student’s t-test), 
while ns (non-significant), #p<0.05 and ##p<0.01 show a comparison of all treatments with HFD (One way-ANOVA followed by 
Tukey’s post-test). POL4 (polyherbal formulation); Ns (N. sativa); Ci (C. intybus); Tfg (T. foenum graecum); Gs (G. sylvestre); ND 
(normal diet); HFD (high fat diet); Atorva (atorvastatin).
al., 2002), POL4 and its individual components [N. sativa, 
C. intybus, T. foenum graecum,G. sylvestre] mixed in diet 
were administered to HFD-fed rats. These interventions 
prevented raised serum total cholesterol (TC), low-density 
lipoprotein-cholesterol (LDL-C), triglycerides (TG), C-
reactive proteins (CRP), atherogenic index (AI), coronary 
risk index (CRI) and fasting blood glucose. Similarly, 
atorvastatin (suspended in distilled water and 
administered through oral gavage) also reduced the raised 
lipid profile. The treatment with POL4 and its ingredients 
also significantly increased high-density lipoprotein-
cholesterol (HDL-C) compared to only HFD-fed rats. The 
body weight was compromised accompanied by a 
reduction in daily feed intake in intervention groups 
compared to HFD fed rats. These findings have clearly 
suggested that POL4 affects cholesterol/lipoprotein 
distribution and plays a part in uptake of HDL-C, thus 
resulting in an up-regulation of LDL-C hepatic receptors 
known to catabolize increased LDL-C(Krause et al., 
1984). This may be due to the presence of a potent 
antioxidant, ascorbic acid or tocopherols in POL4 (Razavi 
and Hosseinzadeh, 2014; Vanamala et al., 2012), while 
presence of polyphenols, 4-hydroxyisoleucine, saponins 
and soluble fibers in T. foenum graecum, known for lipid 
lowering effect, may have a contributing role in observed 
antihyperlipidemic effects (Chaturvedi et al., 2013; Madar 
and Stark, 2002).  
 
High fat diet containing cholesterol, cholic acid and 
butterfat at 2, 0.5 and 5% w/w, respectively, is known to 
alter lipid peroxidation and antioxidant enzymes resulting 
in increased oxidative stress leading to development of 
obesity, vascular dysfunction and hypertension in 
experimental animals (Tobert, 2003; Olusi, 2002). 
Increased body weight and/or adipocyte hypertrophy, 
hepatic steatosis and visceral adiposity are the outcomes 
of chronic use (Jin et al., 2013). Prolonged use of HFD 
enhances serum TC, very low density lipoprotein-
cholesterol (VLDL-C), LDL-C, AI and CRI (Mopuri and 
Meriga, 2014). The cholic acid is well known to help 
cholesterol and fat assimilation and also blocks the 
conversion of cholesterol into bile acid, hence causing 
increase in the pool of cholesterol in serum(Ando et al., 
2005). Thus, the test material(s) offering protection 
against hyperlipidemia in HFD-fed animal model may be 
because of its inhibitory influence on cholesterol and fat 
absorption from dietary source as observed on the part of 
POL4 and its ingredients. 
 
Oxidative stress, one of the characteristic features of HFD 
administration, is a major culprit in development of 
hypercholesterolemia, endothelium-dependent dys-
function and atherosclerosis. Triggered oxidative stress 
along with hypercholesterolemia has synergistic role to 
accelerate the development of vascular resistance, 
hypertension and associated complications like coronary 
artery disease, myocardial ischemia and myocardial 
infarction in animals and humans (Tobert, 2003; Lind, 
2002). When assessed for effect on systolic blood 
pressure (SBP) and endothelial function, the parent 
formulation and its components have decreased SBP and 
improved the endothelium-dependent relaxation by 
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causing an increase in ACh-induced relaxation in 
following orders: Ci>Tfg>POL4Ns. This study reports 
first time the blood pressure lowering and endothelial 
modulating properties of POL4 and C. intybus in HFD-fed 
rats, however, G. sylvestre has been found relatively the 
least effective as antihypertensive which is also in line 
with previous studies for its antihypertensive effect in 
different animal models (Preuss et al., 1998; Bhansali et 
al., 2013). Similarly, the weak endothelial modulatory 
activity has been observed on the part of G. sylvestre 
indicating that its exclusion from current form of the 
formulation may be suggested if used for the treatment of 
hypertension.   
 
Numerous studies have reported that high fat diet 
significantly increases body weight by causing 
accumulation of adipose tissue (Hariri and Thibault, 2010; 
Reuter, 2007). The present study has demonstrated that 
HFD intake induces obesity which was evident by the 
significant weight gains in HFD-fed animals. The 
administration of POL4 and its components to HFD-fed 
rats have exhibited beneficial effects on weight gain and 
food intake as compared to HFD-fed rats without any 
treatment. This contribution might be because of the 
existence of some of the secondary metabolites in N. 
sativa like thymoquinone and tocopherols and in G. 
sylvestre like gymnemic acid and deacylgemnemic acid 
which are known for their antiobesity activities (Hasani-
Ranjbar et al., 2013; Pothuraju et al., 2014; Manish et al., 
2011). 
 
CONCLUSION 
       
This study has shown that POL4 and its ingredients 
possess antihyperlipidemic, endothelium- modulating and 
antihypertensive properties. The antihyperlipidemic 
property may be attributed to the inhibitory influence of 
POL4 on absorption and synthesis of lipids. Thus, this 
study provides an evidence to the empirical medicinal use 
of POL4 and its constituents in cardiovascular disorders 
like hyperlipidemia and hypertension.  
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